You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Colorcon
Mallinckrodt
Moodys
Express Scripts

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMIODARONE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Amiodarone Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000464 Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1987-04-01 To compare the efficacy of amiodarone to conventional anti-arrhythmic therapy in individuals who had survived one episode of out-of-hospital cardiac arrest.
NCT00000464 Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE) Completed University of Washington Phase 3 1987-04-01 To compare the efficacy of amiodarone to conventional anti-arrhythmic therapy in individuals who had survived one episode of out-of-hospital cardiac arrest.
NCT00000531 Antiarrhythmics Versus Implantable Defibrillators (AVID) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1992-09-01 To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated from sudden cardiac death who are otherwise at very high risk of mortality from arrhythmic causes.
NCT00000556 Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1995-03-01 To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation.
NCT00000609 Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1997-05-01 To compare conventional treatment of congestive heart failure (CHF) with two experimental interventions: amiodarone and an implantable cardioverter-defibrillator (ICD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Amiodarone Hydrochloride

Condition Name

Condition Name for Amiodarone Hydrochloride
Intervention Trials
Atrial Fibrillation 57
Ventricular Tachycardia 8
Heart Failure 7
Heart Diseases 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Amiodarone Hydrochloride
Intervention Trials
Atrial Fibrillation 71
Tachycardia 16
Tachycardia, Ventricular 15
Heart Diseases 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Amiodarone Hydrochloride

Trials by Country

Trials by Country for Amiodarone Hydrochloride
Location Trials
United States 208
Italy 68
Canada 36
Spain 13
France 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Amiodarone Hydrochloride
Location Trials
Pennsylvania 12
New York 12
California 11
Virginia 10
Texas 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Amiodarone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Amiodarone Hydrochloride
Clinical Trial Phase Trials
Phase 4 43
Phase 3 32
Phase 2/Phase 3 6
[disabled in preview] 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Amiodarone Hydrochloride
Clinical Trial Phase Trials
Completed 50
Not yet recruiting 27
Recruiting 21
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Amiodarone Hydrochloride

Sponsor Name

Sponsor Name for Amiodarone Hydrochloride
Sponsor Trials
Sanofi 6
National Heart, Lung, and Blood Institute (NHLBI) 6
Biosense Webster, Inc. 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Amiodarone Hydrochloride
Sponsor Trials
Other 179
Industry 36
NIH 9
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Harvard Business School
Mallinckrodt
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.